Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures

Conditions

• Epilepsy

Interventions

• DRUG: ESL 800 mg
• DRUG: ESL 1200 mg
• DRUG: ESL 1600 mg
• DRUG: ESL 400 mg

Sponsor

Bial - Portela C S.A.